France’s Minister of Higher Education and Research Geneviève Fioraso reinstated the country’s Operation Campus program in October. The program was first announced in 2007 to increase the competitiveness of French universities (see IBO 7/15/08). Under the plan, pôles de recherche et enseignement supérieur (centers for research and higher education), clusters of universities, grandes écoles (“higher […]
Spain’s pharmaceutical R&D spending dropped 5.3% to €974 million ($1.3 billion) in 2011, which is the lowest amount since 2007. In 2010, pharmaceutical R&D spending increased 6.5% to €1.0 billion. Spending on clinical trials accounted for 48% of R&D spending, and basic research represented 14%. Fourteen percent of pharmaceutical R&D spending in 2011 was for […]
Much of the focus for analytical instrument sales in Asia has been on China and India. However, other areas in Asia Pacific, particularly continental Southeast Asia, which is comprised of Cambodia, Laos, Malaysia, Myanmar, Singapore, Thailand and Vietnam, exhibit strong growth opportunities. Sales of analytical instrumentation (see box, page 8) in Asia Pacific grew more […]
Australia’s midyear budget will cut Sustainable Research Excellence (SRE) grants by 40% to AUD 79 million ($81.9 million) for 2012–2013. Although research grants were not subject to cuts, the SRE grants, which have supported overhead expenses for research since 2009, will receive AUD 499 million less over the next four years than originally announced. Funding […]
R&D spending in China continued to grow in 2011, increasing 23% to CNY 868.7 billion ($139 billion). R&D spending accounted for 1.84% of the country’s GDP, up from 1.76% in 2010. Investment in basic research, applied research and experimental development, a term the Chinese government defines as “systematic activities aiming at using the knowledge from […]
The Turkish Association of Research-Based Pharmaceutical Companies’ (AFID) “Vision 2023” report released earlier this month recommends ways to make the country among the top 10 countries in health services by 2023. Turkey’s pharmaceutical market was valued at $11.2 billion in 2011, ranking 16th in the world. However, in 2011, Turkey’s 70 clinical trials supported by […]
According to the results of IBO’s Fall 2012 Business Climate Survey, expectations for near-term instrument and laboratory product sales have hit their lowest point since spring 2009 (see graph, page 6). Twenty-four percent of respondents expect instrument and lab product sales to decline industry wide over the calendar-year fourth quarter 2012 and first quarter 2013. […]
On September 28, French President François Hollande announced that, despite reductions for other ministries in the 2013 budget, the Higher Education and Research Ministry will receive a 2.2% funding increase to nearly €23 billion ($29 billion), or €26 billion including funding from other ministries. The budget for research grants will increase 1.2% to €7.86 billion, […]
Earlier this month, the European Commission (EC) released the “Communication on the Second Regulatory Review on Nanomaterials” report (the Review), along with a Working Paper on nanomaterial types and uses (the Working Paper). The Review highlighted the potential benefits of new nanomaterials and new uses, including electronics, solar panels, batteries and biomedical applications. Established uses […]
The Chinese State Food and Drug Administration’s (SFDA) new GMP regulations could result in a restructure of the country’s drug industry. In March 2011, the SFDA announced new GMP regulations, which firms must adhere to by December 2015. Chinese drug exports conform to European, US and Japanese regulations, so Chinese firms that export active pharmaceutical […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
